The University of Queensland’s Clinical Trials Capability (ULTRA)

The ULTRA program brings together a highly skilled interdisciplinary team focused on creating innovation in RCTs that leads to higher quality trials, more robust and rapid results and improved outcomes for patients and the public.

We offer methodological capability for innovative RCTs in existing and new areas of clinical research led by The University of Queensland; working across UQ’s Faculties and Schools, Institutes, Centres and external partners in design and analysis of innovative trials, embedding qualitative research and implementation science in trials, facilitating trials to deliver on time and target, and translate findings into practice.

Funded through The University of Queensland’s Vice-Chancellors Health Research Accelerator (HERA) initiative to tackle urgent health and medical challenges, ULTRA is working together with the UQ’s Clinical Trials Centre (CTC) to augment existing expertise and accelerate RCT capability, capacity, co-ordination and competitiveness.

Vision

To create Australia’s most successful interdisciplinary team leading innovative RCTs that deliver results rapidly, translated for public good.

Mission

Accelerate The University of Queensland’s capability, capacity, co-ordination and competitiveness in innovative and impactful RCTs.

Professor Nadine Foster (Director - ULTRA)

Nadine is an internationally recognised leader in clinical trials and Academic Director of The University of Queensland’s (UQ) Clinical Trials Centre (CTC). She is passionate about supporting the development and delivery of high quality innovative randomised clinical trials (RCTs) that translate into better patient outcomes.

Nadine is the programme lead for the HERA ULTRA initiative – creating and supporting Australia’s most successful interdisciplinary team leading innovative RCTs that deliver results rapidly, translated for patient benefit. ULTRA forms a core part of UQ CTC and is integrated with the CTC to support existing RCTs and co-develop future RCTs.

Professor Andrew Martin 

Andrew is the inaugural Professor of Innovative Clinical Trials and leads the University of Queensland’s ULTRA program.  He has made original, innovative and distinguished contributions to methodological research, as well as the design, conduct, analysis, interpretation, and dissemination of clinical research that has had an impact at an international level policy, practice, and subsequent research programs.

Associate Professor Ingrid Hickman

Dr Nathalia Costa

As part of the ULTRA team, Nathalia works collaboratively with researchers, consumers and other stakeholders to enhance trial designs and processes through innovative qualitative methods and methodologies – from identifying trial questions to improving equipoise, recruitment and retention.  Nathalia’s research draws from a range of qualitative and mixed methodologies to make meaningful contributions to clinical trials and healthcare more broadly.

Dr Ding Ma

Ding is a post-doctoral research fellow in biostatistics within the ULTRA team, specialising in the development of estimation methods for semiparametric survival models and their extensions. He is dedicated to advancing statistical methodologies for biostatistics applications, including the design and analysis of clinical trials.

Dr Mark Liu

Mark is an implementation scientist within the ULTRA team, with experience in behaviour change research on the patient, clinician and organisational level. He has methodological expertise in conducting pragmatic research in real-world settings, implementation and behavioural theory, and leveraging routinely collected health data as research outcome measures. He is also a strong advocate for consumer involvement across all stages of research.

Patrick Maher

Patrick is a senior research assistant within the ULTRA team working as a biostatistician with a particular interest in simulation and analyses of data within clinical trials. Patrick is currently completing his BCA Masters of Biostatistics.

Researchers from many UQ Faculties and Institutes work and collaborate with ULTRA including:

• Faculty of Medicine
• Faculty of Health and Behavioural Sciences
• Faculty of Business, Economics and Law
• Institute of Molecular Bioscience
• Queensland Brain Institute

Affiliates

We thank and acknowledge the following UQ staff and Academic Title Holders who collaborated to support the objectives of ULTRA, and who are now affiliates of ULTRA. 

• Professor Jason Roberts
• Dr Roberta Littleford
• Dr Jon Fanning
• Professor Carmel Hawley
• Ms Donna Reidlinger
• Ms Elaine Pascoe
• Professor Jason Ferris
• Associate Professor Mark Chatfield
• Professor Tracy Comans
• Professor Karen Barlow
• Associate Professor Kirsten Gibbons
• Professor Rosyln Boyd
• Professor Craig Munns
• Professor Elizabeth Eakin
• Dr Louise Marquart
• Dr Michael Waller
• Professor Annette Dobson
• Dr Reza Baneshi
• Professor Claire Rickard
• Professor Amanda Ullman
• Professor Haitham Tuffaha
• Professor Paul Hodges
• Professor Trevor Russell
• Professor Michele Sterling
• Associate Professor Shaun O’Leary
• Dr Natalie Collins
• Dr Guido Zuccon
• Professor Maher Gandhi
• Professor Sailesh Kumar
• Professor Janet Hardy
• Professor Dan Chambers
• Professor John Upham
• Associate Professor Andy Moore

Partners

Our external partners include:

• Queensland Health
• Health Translation Queensland
• Metro North Hospital and Health Service
• Metro South Hospital and Health Service
• Queensland Children's Hospital
• Mater
• QCIF - Queensland Cyber Infrastructure Foundation
• Australia Clinical Trials Alliance (ACTA).